Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss
Conditions: Alopecia Interventions: Drug: DNN.22.17.036; Drug: 10573048700 Sponsors: Ache Laboratorios Farmaceuticos S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias
Conditions: Lichen Planopilaris of Scalp; Alopecia Areata Interventions: Device: Venus Glow Sponsors: University of Minnesota Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)
Conditions: Alopecia Areata Interventions: Drug: Rezpegaldesleukin; Drug: Placebo Sponsors: Nektar Therapeutics Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss
Conditions: Dermatology; Female Pattern Baldness Interventions: Drug: Topical minoxidil; Drug: Topical Vitamin D; Drug: Saline spray Sponsors: Sohag University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials
Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata
Conditions: Alopecia Areata Interventions: Drug: Lactic Acid; Drug: vit D; Drug: Triamcinolone Acetonide; Drug: Saline Sponsors: Zagazig University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Autologous Stromal Vascular Fraction in Treatment of Male Androgenic Alopecia
Conditions: Androgenic Alopecia Interventions: Procedure: autologous stromal vascular fraction Sponsors: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases
Conditions: Psoriasis; Alopecia Areata; Hidradenitis Suppurativa; Vitiligo; Atopic Dermatitis Interventions: Behavioral: HautKompass Sponsors: Universit ätsklinikum Hamburg-Eppendorf; German Federal Ministry of Education and Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo
Conditions: Alopecia Areata; Vitiligo; Atopic Dermatitis; Psoriasis Interventions: Other: Observational Sponsors: Blueskin AS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Effectiveness of Ultrapulse for the Treatment of Androgenic Alopecia Among Malaysian: A Quasi-experimental Study
Conditions: Androgenic Alopecia; Alopecia Interventions: Device: Er:YAG laser Sponsors: Universiti Tunku Abdul Rahman Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
Systemic Treatments for Alopecia Areata Registry
Conditions: Alopecia Areata; Alopecia Totalis; Alopecia Universalis; Hair Loss; Hair Diseases; Alopecia; Alopecia Drugs; Autoimmune Diseases Sponsors: Erasmus Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Litfulo Capsules Special Investigation
Conditions: Alopecia Areata Interventions: Drug: LITFULO Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.
Conditions: Alopecia Areata; Alopecia Totalis; Alopecia Universalis Interventions: Drug: Tofacitinib Sponsors: Jinnah Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
Clinical Workflow Optimization Using Artificial Intelligence for Dermatological Conditions
Conditions: Acne; Acne Vulgaris; Alopecia, Androgenetic; Pigmented Lesions; Pigmented Skin Lesion Sponsors: AI Labs Group S.L; Instituto de Dermatolog ía Integral (IDEI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)
Conditions: Frontal Fibrosing Alopecia Interventions: Drug: Baricitinib 4 MG Oral Tablet Sponsors: University of Alabama at Birmingham; Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Evaluation of Latanoprost Combined With Fractional Erbium- YAG Laser
Conditions: Alopecia Areata Interventions: Drug: Latanoprost Sponsors: Egymedicalpedia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials
